Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

SHSE:688336 Rapporto sulle azioni

Cap. di mercato: CN¥14.3b

Sunshine Guojian Pharmaceutical (Shanghai) Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione4.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet

Nov 19
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet

Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 29
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump

Oct 01
There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump

What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You

Jul 25
What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You

Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?

Jun 20
Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?

If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity

May 24
If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity

We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings

Mar 31
We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 04
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

AMMINISTRATORE DELEGATO

Sunshine Guojian Pharmaceutical (Shanghai) non ha un CEO, o non abbiamo dati su di loro.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Dongmei Su
Director2.2yrsNessun datoNessun dato
Jing Lou
Chairman of the Board8.7yrsCN¥993.10k4.08%
CN¥ 582.2m
Wei Zhang
Independent Director5.3yrsCN¥136.80kNessun dato
Yongli Jin
Independent Director5.3yrsCN¥136.80kNessun dato
Fanzhi Huang
Independent Director3.4yrsCN¥136.80kNessun dato
Jing Wu
Employee Representative Supervisor3.2yrsNessun datoNessun dato

4.3yrs

Durata media

59yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 688336 sono considerati esperti (durata media dell'incarico 4.3 anni).